PCSK9 and atherosclerosis: Overexpression of PCSK9 was found to inversely downregulate the expression of LDLR and reduce the clearance of cholesterol from plasma, so inhibiting PCSK9 overexpression is significant in the prevention and treatment of atherosclerosis.